Ranibizumab in neovascular age-related macular degeneration: a 5-year follow-up

QR Code

Ranibizumab in neovascular age-related macular degeneration: a 5-year follow-up

Nadezhda P Cvetkova, Kristina Hölldobler, Philipp Prahs, Viola Radeck, Horst Helbig, David Märker Department of Ophthalmology, University of Regensburg, Regensburg, Germany Purpose: Our aim was to evaluate an optical coherence tomography (OCT) and visual acuity (VA)-guided, varia...

Description complète

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Cvetkova NP, Hölldobler K, Prahs P, Radeck V, Helbig H, Märker D
Format:	article
Langue:	EN
Publié:	Dove Medical Press 2016
Sujets:	AMD neovascular OCT Ranibizumab Retina Ophthalmology RE1-994
Accès en ligne:	https://doaj.org/article/034123d2f1cb4cb182f09727e4b49dd7
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Visual outcome of intravitreal ranibizumab for exudative age-related macular degeneration: timing and prognosis
par: Canan H, et autres
Publié: (2014)

Randomised, Double-blind, Comparative Clinical Study of New Ranibizumab Biosimilar in Neovascular (Wet) Age-Related Macular Degeneration
par: Apsangikar P, et autres
Publié: (2021)

Combination of ranibizumab and indomethacin for neovascular age-related macular degeneration: randomized controlled trial
par: Russo A, et autres
Publié: (2018)

Neovascular age-related macular degeneration: intraocular inflammatory cytokines in the poor responder to ranibizumab treatment
par: Pongsachareonnont P, et autres
Publié: (2018)

Three-year follow-up of ranibizumab treatment of wet age-related macular degeneration: influence of baseline visual acuity and injection frequency on visual outcomes
par: Razi F, et autres
Publié: (2016)

OCT Angiography-based Evaluation of the Choriocapillaris in Neovascular Age-related Macular Degeneration
par: Varsha Pramil, et autres
Publié: (2021)

Results of switchback from ranibizumab to aflibercept in patients with exudative age-related macular degeneration
par: Koike N, et autres
Publié: (2019)

Worsening anatomic outcomes following aflibercept for neovascular age-related macular degeneration in eyes previously well controlled with ranibizumab
par: Nudleman E, et autres
Publié: (2016)

Preoperative intravitreal Ranibizumab with panretinal photocoagulation followed by conventional trabeculectomy without drainage device for neovascular glaucoma
par: Xiao-Dong Han, et autres
Publié: (2021)

Long-Term Ranibizumab Treatment in Neovascular Age-Related Macular Degeneration: A Belgian Subanalysis from the Global Real-World LUMINOUSTM Study
par: Leys AM, et autres
Publié: (2020)

Comparing Effectiveness of Three Different Anti-VEGF Treatment Regimens for Neovascular Age-Related Macular Degeneration: Two Years’ Real-World Clinical Outcomes
par: Horner F, et autres
Publié: (2021)

Real-World Effectiveness, Treatment Pattern, and Safety of Ranibizumab in Korean Patients with Neovascular Age-Related Macular Degeneration: Subgroup Analyses from the LUMINOUS Study
par: Sagong M, et autres
Publié: (2021)

Evaluation of contrast sensitivity and other visual function outcomes in neovascular age-related macular degeneration patients after treatment switch to aflibercept from ranibizumab
par: Nixon DR, et autres
Publié: (2017)

Treatment of myopic choroidal neovascularization with intravitreal ranibizumab injections: the role of age
par: Karagiannis D, et autres
Publié: (2017)

Choriocapillaris Vascular Density Changes: Healthy vs. Advanced Exudative Age-Related Macular Degeneration Previously Treated with Multiple Anti-VEGF Intravitreal Injections
par: Maria Cristina Savastano, et autres
Publié: (2021)

Long-term follow-up of patients with choroidal neovascularization due to angioid streaks
par: Martinez-Serrano MG, et autres
Publié: (2016)

Initiation and maintenance of a Treat-and-Extend regimen for ranibizumab therapy in wet age-related macular degeneration: recommendations from the UK Retinal Outcomes Group
par: Amoaku W, et autres
Publié: (2018)

Aqueous humor cytokine levels through microarray analysis and a sub-analysis based on optical coherence tomography in wet age-related macular degeneration patients
par: Jin-Ho Joo, et autres
Publié: (2021)

One-year outcome of intravitreal aflibercept injection for age-related macular degeneration resistant to ranibizumab: rapid morphologic recovery and subsequent visual improvement
par: Hirakata T, et autres
Publié: (2016)

Five-year outcomes of intravitreal drug therapy for neovascular age-related macular degeneration in eyes with baseline vision 20/60 or better
par: Khanani AM, et autres
Publié: (2019)

Twelve-week dosing with Aflibercept in the treatment of neovascular age-related macular degeneration
par: Garweg JG
Publié: (2019)

ANTI-ANGIOGENIC THERAPY IN PATIENTS WITH PATHOLOGIC MYOPIA AND CHOROIDAL NEOVASCULARIZATION
par: S. A. Korotkikh, et autres
Publié: (2016)

Two-year outcome of treat-and-extend aflibercept after ranibizumab in age-related macular degeneration and polypoidal choroidal vasculopathy patients
par: Azuma K, et autres
Publié: (2018)

Cost-Effectiveness of Conbercept vs. Ranibizumab for Age-Related Macular Degeneration, Diabetic Macular Edema, and Pathological Myopia: Population-Based Cohort Study and Markov Model
par: Zhuang Cui, et autres
Publié: (2021)

Quantifying choriocapillaris hypoperfusion in patients with choroidal neovascularization using swept-source OCT angiography
par: Keiner CM, et autres
Publié: (2019)

Factors for Visual Acuity Improvement After Anti-VEGF Treatment of Wet Age-Related Macular Degeneration in China: 12 Months Follow up
par: Yan Lu, et autres
Publié: (2021)

No improvement in injection frequency or in visual outcome over time in two cohorts of patients from the same Swedish county treated for wet age-related macular degeneration
par: Schroeder M, et autres
Publié: (2017)

Choroidal neovascularization complicating sclerochoroidal calcifications
par: Maurizio Battaglia Parodi, et autres
Publié: (2021)

Ranibizumab treatment history as predictor of the switch-response to aflibercept: evidence for drug tolerance
par: Dirani A, et autres
Publié: (2018)

Two-year analysis of changes in the optic nerve and retina following anti-VEGF treatments in diabetic macular edema patients
par: Filek R, et autres
Publié: (2019)

Anti-vascular endothelial growth factor therapy for the treatment of myopic choroidal neovascularization
par: Tan CS, et autres
Publié: (2017)

Combination verteporfin photodynamic therapy ranibizumab-dexamethasone in choroidal neovascularization due to age-related macular degeneration: results of a phase II randomized trial
par: Gallemore RP, et autres
Publié: (2017)

Real-World Visual And Clinical Outcomes For Patients With Neovascular Age-Related Macular Degeneration Treated With Intravitreal Ranibizumab: An 8-Year Observational Cohort (AMD8)
par: Horner F, et autres
Publié: (2019)

Subclinical Signs of Retinal Involvement in Hereditary Angioedema
par: Paola Triggianese, et autres
Publié: (2021)

Multimodal imaging and diagnosis of myopic choroidal neovascularization in Caucasians
par: Milani P, et autres
Publié: (2016)

Correlation of Baseline Visual Acuity with Outcomes of Treatment with Anti-VEGF in Neovascular Age-Related Macular Degeneration
par: Veluswamy B, et autres
Publié: (2020)

Comment on: “Three-year follow-up of ranibizumab treatment of wet age-related macular degeneration: influence of baseline visual acuity and injection frequency on visual outcomes”
par: Kaya A
Publié: (2016)

A retrospective study of the real-life utilization and effectiveness of ranibizumab therapy for neovascular age-related macular degeneration in the UK
par: Hykin P, et autres
Publié: (2016)

Efficacy and safety of ranibizumab monotherapy versus ranibizumab in combination with verteporfin photodynamic therapy in patients with polypoidal choroidal vasculopathy: 12-month outcomes in the Japanese cohort of EVEREST II study
par: Takahashi K, et autres
Publié: (2018)

Macular morphology and response to ranibizumab treatment in patients with wet age-related macular degeneration
par: Dervenis N, et autres
Publié: (2016)